{"id":12650,"date":"2019-03-28T17:20:44","date_gmt":"2019-03-28T16:20:44","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=12650"},"modified":"2019-04-02T17:21:16","modified_gmt":"2019-04-02T15:21:16","slug":"proteonic-biotechnology-licenses-protein-production-technology-to-bayer","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\/","title":{"rendered":"ProteoNic Biotechnology licenses Protein Production technology to Bayer"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">ProteoNic Biotechnology has licensed its 2G UNic\u2122 technology for boosting recombinant protein production to the pharmaceutical company Bayer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Under the agreement, Bayer gains non-exclusive, worldwide commercial rights for application of the technology to the development of its proprietary products. Financial details of the agreement were not disclosed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The companies reached agreement following evaluation of the technology by Bayer regarding levels of recombinant protein production as well as product characteristics.&nbsp; Bayer will present the data at the Conference \u201cCell Line Development and Engineering Europe 2019\u201d, held in Vienna April 2-4, by Dr. Anke Mayer-Bartschmid.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">ProteoNic\u2019s protein expression technology is designed to improve cell line production levels across a range of host cells, selection systems and protein targets. This is achieved via the combined effect of novel genetic elements, which synergistically exert a positive effect on recombinant protein production levels.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">ProteoNic\u2019s 2G UNic\u2122 can be combined with other expression-enhancing technologies to improve their performance.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Frank Pieper, CEO of ProteoNic commented: \u201cProteoNic\u2019s clients consistently observe commercially relevant improvement of cell line productivity by adding 2G UNic\u2122 to their best expression system or by applying 2G UNic\u2122 in a stand-alone fashion.\u00a0 We believe that current expression systems have much room for improvement, and that 2G UNic\u2122 technology can make an important contribution to the economically viable production of both innovator and biosimilar products. We will continue our work to reach maximum potential of the production of biologicals for current and future clients\u201d.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Source: <strong>Proteonic<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ProteoNic Biotechnology has licensed its 2G UNic\u2122 technology for boosting recombinant protein production to the pharmaceutical company Bayer. Under the agreement, Bayer gains non-exclusive, worldwide commercial rights for application of the technology to the development of its proprietary products. Financial details of the agreement were not disclosed. The companies reached agreement following evaluation of the [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[43],"tags":[],"class_list":["post-12650","post","type-post","status-publish","format-standard","hentry","category-innovatieklimaat"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ProteoNic Biotechnology licenses Protein Production technology to Bayer - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProteoNic Biotechnology licenses Protein Production technology to Bayer - hollandbio\" \/>\n<meta property=\"og:description\" content=\"ProteoNic Biotechnology has licensed its 2G UNic\u2122 technology for boosting recombinant protein production to the pharmaceutical company Bayer. Under the agreement, Bayer gains non-exclusive, worldwide commercial rights for application of the technology to the development of its proprietary products. Financial details of the agreement were not disclosed. The companies reached agreement following evaluation of the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2019-03-28T16:20:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-04-02T15:21:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"hollandbio\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hollandbio\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\\\/\"},\"author\":{\"name\":\"hollandbio\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/833d6a25b39946e61c6101af1fa96fbb\"},\"headline\":\"ProteoNic Biotechnology licenses Protein Production technology to Bayer\",\"datePublished\":\"2019-03-28T16:20:44+00:00\",\"dateModified\":\"2019-04-02T15:21:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\\\/\"},\"wordCount\":251,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"Innovatieklimaat\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\\\/\",\"name\":\"ProteoNic Biotechnology licenses Protein Production technology to Bayer - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2019-03-28T16:20:44+00:00\",\"dateModified\":\"2019-04-02T15:21:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProteoNic Biotechnology licenses Protein Production technology to Bayer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/833d6a25b39946e61c6101af1fa96fbb\",\"name\":\"hollandbio\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProteoNic Biotechnology licenses Protein Production technology to Bayer - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\/","og_locale":"en_US","og_type":"article","og_title":"ProteoNic Biotechnology licenses Protein Production technology to Bayer - hollandbio","og_description":"ProteoNic Biotechnology has licensed its 2G UNic\u2122 technology for boosting recombinant protein production to the pharmaceutical company Bayer. Under the agreement, Bayer gains non-exclusive, worldwide commercial rights for application of the technology to the development of its proprietary products. Financial details of the agreement were not disclosed. The companies reached agreement following evaluation of the [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\/","og_site_name":"hollandbio","article_published_time":"2019-03-28T16:20:44+00:00","article_modified_time":"2019-04-02T15:21:16+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"hollandbio","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"hollandbio","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\/"},"author":{"name":"hollandbio","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/833d6a25b39946e61c6101af1fa96fbb"},"headline":"ProteoNic Biotechnology licenses Protein Production technology to Bayer","datePublished":"2019-03-28T16:20:44+00:00","dateModified":"2019-04-02T15:21:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\/"},"wordCount":251,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["Innovatieklimaat"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\/","name":"ProteoNic Biotechnology licenses Protein Production technology to Bayer - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2019-03-28T16:20:44+00:00","dateModified":"2019-04-02T15:21:16+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-biotechnology-licenses-protein-production-technology-to-bayer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"ProteoNic Biotechnology licenses Protein Production technology to Bayer"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/833d6a25b39946e61c6101af1fa96fbb","name":"hollandbio"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/12650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=12650"}],"version-history":[{"count":0,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/12650\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=12650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=12650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=12650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}